| Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure. | |
| | |
MedLine Citation:
|
PMID: 11717621 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Insulin-like growth factor 1 (IGF-1) promotes favorable cardiac remodeling in heart failure. However, the relation of plasma IGF-1 in patients with various degrees of heart failure is not known. METHODS: Venous plasma samples were collected from patients with clinically documented heart failure (n = 24) and from control subjects (n = 21) for measurements of IGF-1 levels. In the heart failure group, functional assessment of the physical capacity was determined by means of the New York Heart Association (NYHA) score. Objective determination of ventricular performance was made by transthoracic echocardiographic measurement of left ventricular fractional shortening (FS). RESULTS: IGF-1 levels were higher in patients with heart failure (mean age, 67 +/- 2 years; 17 men) than in control subjects (age, 71 +/- 2 years; 9 men) (20.2 +/- 2 mU/L, 14.1 +/- 2 mU/L, respectively, P <.05). However, the elevated IGF-1 levels were demonstrated only in patients with mild-to-moderate symptoms (NYHA classes I and II) of heart failure (24.7 +/- 3.3 mU/L, n = 12, P =.005 vs control subjects) but not in patients with severe symptoms (NYHA classes III and IV) (15.7 +/- 2.3 mU/L, n = 12). There was a strong positive correlation between IGF-1 levels and left ventricular FS (%) (r = 0.58, P =.003, n = 24). Adjustments for other potential confounders including age, sex, treatment received, and underlying cause of heart failure did not alter the relation between IGF-1 and left ventricular FS (odds ratio, 2.01; 95% confidence interval, 1.26 to 6.24; P =.01). CONCLUSIONS: Plasma levels of IGF-1 show distinct variations with the severity of heart failure and may play a vital role in compensated heart failure. |
| | |
Authors:
|
M K Al-Obaidi; J K Hon; P J Stubbs; J Barnes; R A Amersey; M Dahdal; J F Laycock; M I Noble; J Alaghband-Zadeh |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: American heart journal Volume: 142 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2001 Dec |
Date Detail:
|
Created Date: 2001-11-21 Completed Date: 2001-12-07 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States |
Other Details:
|
Languages: eng Pagination: E10 Citation Subset: AIM; IM |
Affiliation:
|
National Heart and Lung Institute, Department of Cardiology, Imperial College School of Medicine, London, UK. m.al-obaidi@rbh.nthames.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Female Heart Failure / blood*, classification* Humans Insulin-Like Growth Factor I / analysis* Linear Models Male |
| Chemical | |
Reg. No./Substance:
|
67763-96-6/Insulin-Like Growth Factor I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Characteristics and outcomes among patients undergoing coronary artery bypass grafting in western Sw...
Next Document: Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-a...